WGS 9-DAY DEADLINE ALERT: GeneDx Holdings Corp. (NASDAQ: WGS) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 3, 2026 Lead Plaintiff Deadline

Investors in GeneDx Holdings Corp. (NASDAQ: WGS) who purchased shares between April 16, 2025 and May 4, 2026, are urged to contact Hagens Berman Sobol Shapiro LLP regarding a securities fraud class action lawsuit with an upcoming lead plaintiff deadline of August 3, 2026.

The action centers on whether GeneDx misled investors by selling a vision of seamless technological synergy while concealing internal realities. The lawsuit alleges that GeneDx and certain top executives made materially false and misleading statements regarding the strategic and financial benefits of the company's acquisition of Fabric Genomics. Defendants allegedly touted Fabric as an AI-driven growth catalyst designed to unlock recurring software-based revenue streams, optimize dry lab processes, and reduce cost of goods sold (COGS).

In truth, defendants allegedly knew of, or recklessly disregarded, significant problems regarding Fabric's viability, integration hurdles, and operational disconnects that severely harmed GeneDx's overall business. The artificial inflation came to an abrupt end on May 4, 2026, when GeneDx reported its first-quarter 2026 financial results after the market closed, reporting missed revenue estimates, a drop in adjusted gross margins, dramatically lowered full-year revenue guidance, and a staggering $31.2 million impairment loss directly attributable to Fabric Genomics.

Following these disclosures, WGS shares plummeted 49.2% in a single session, destroying billions in shareholder value.